Croissant ou pain au chocolat, quelle viennoiserie est la meilleure à manger le matin au petit-déjeuner pour notre glycémie ? On vous dévoile la réponse avec l'index glycémique du croissant et du pain ...

Staff Writer for The Prospect Lulu Pettit reviews the recently-opened French cafe on Chambers Street called Belle Journée to ...

L'alimentation est un sujet qui ne laisse personne indifférent : alors que d'aucuns ne jurent que par certaines règles, ...

Vous pensez manger sainement en prenant votre tranche de pain matinale ou en savourant un carré de chocolat ? Mauvaise nouvelle : ces aliments du quotidien contiennent du cadmium, un métal lourd toxiq ...

The drug, called Journavx (suzetrigine) and manufactured by biotech company Vertex Pharmaceuticals, is a non-opioid painkiller, which doesn’t have addictive properties, unlike opioids often used for ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

When you walk into the bakery craving that iconic, buttery, flaky breakfast pastry with a dark chocolate centre, do you ask for a pain au chocolat or a chocolatine? The answer to that question ...

The approval marks the first new class of pain medicine in more than two decades and offers a potential non-addictive alternative to opioids. "Today's approval is a historic milestone for the 80 ...

The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first non-opioid analgesic – or ...